Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide dose-setting test for anti-obesity effect in visceral fat obesity with hyperinsulinemia
jRCTs071200028Completed
- Sponsor
- Orphan Pacific
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of diazoxide in Abdominal adiposity (ABCD) and hyperinsulinemia, sponsored by Orphan Pacific. Primary endpoint: Safety and insulin suppression. Started Sep 2020; status: completed.
02
Drugs
diazoxide
03
Conditions
Abdominal adiposity (ABCD)hyperinsulinemia
Beyond the preview
Go deeper on jRCTs071200028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200028.